Remarkably, the Sp1 inhibitor mithramycin A (MMA) decreased the protein levels of EphA3 in RAGE-overexpressing BC cells (F ig. 5I-J), further suggesting that Sp1 can be involved in the regulation of EphA3, as previously reported [63]. This evidence concerns the gene SP1 and breast cancer.